lopinavir-ritonavir drug combination

cytochrome P450 family 3 subfamily A member 4 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34496043 Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients. 2022 Mar 1
2 35607886 Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients. 2022 May 24 1
3 34899329 Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy. 2021 1
4 32864162 Pharmacogenomics of COVID-19 therapies. 2020 1